Regenxbio
(NASDAQ:RGNX)
$22.56
0.15[0.67%]
At close: Dec 8(Delayed 15-Minutes)
Get Real Time Here
$22.56
After Hours: 4:01PM EDT
Day Range22.094 - 22.99052 Wk Range18.690 - 36.350Open / Close22.510 / 22.560Float / Outstanding28.427M / 43.294M
Vol / Avg.199.749K / 342.554KMkt Cap976.704MP/E12.95450d Avg. Price22.730
Div / Yield (Forward)- / -%Payout Ratio-Total Float28.427MEPS1.830

Regenxbio Stock (NASDAQ:RGNX), Quotes and News Summary

Regenxbio Stock (NASDAQ: RGNX) stock price, news, charts, stock research, profile.

Loading...
Day Range22.094 - 22.99052 Wk Range18.690 - 36.350Open / Close22.510 / 22.560Float / Outstanding28.427M / 43.294M
Vol / Avg.199.749K / 342.554KMkt Cap976.704MP/E12.95450d Avg. Price22.730
Div / Yield (Forward)- / -%Payout Ratio-Total Float28.427MEPS1.830
TipRanks - Nov 21, 2022, 11:35AM
Seeking Alpha - Nov 21, 2022, 4:17AM
TipRanks - Nov 4, 2022, 6:25AM
Seeking Alpha - Nov 1, 2022, 5:35PM
Seeking Alpha - Oct 30, 2022, 2:30AM
TipRanks - Sep 1, 2022, 2:15PM
TipRanks - Aug 10, 2022, 12:35PM
Seeking Alpha - Aug 2, 2022, 5:35PM
Sector: Health Care.Industry: Biotechnology
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS-1.460-1.750 -0.2900
REV30.810M26.512M-4.298M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Regenxbio (RGNX) stock?

A

You can purchase shares of Regenxbio (NASDAQ: RGNX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Regenxbio's (RGNX) competitors?

Q

What is the target price for Regenxbio (RGNX) stock?

A

The latest price target for Regenxbio (NASDAQ: RGNX) was reported by Morgan Stanley on Monday, November 21, 2022. The analyst firm set a price target for 50.00 expecting RGNX to rise to within 12 months (a possible 121.63% upside). 15 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Regenxbio (RGNX)?

A

The stock price for Regenxbio (NASDAQ: RGNX) is $22.56 last updated Today at December 8, 2022, 9:00 PM UTC.

Q

Does Regenxbio (RGNX) pay a dividend?

A

There are no upcoming dividends for Regenxbio.

Q

When is Regenxbio (NASDAQ:RGNX) reporting earnings?

A

Regenxbio’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Regenxbio (RGNX) going to split?

A

There is no upcoming split for Regenxbio.

Q

What sector and industry does Regenxbio (RGNX) operate in?

A

Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.